Ignite Creation Date:
2024-05-19 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06415773
Status:
RECRUITING
Last Update Posted:
2024-05-16
First Post:
2024-05-10
Brief Title:
Effects of Berberine Ursodeoxycholate HTD1801 Versus Dapagliflozin in Patients With Type 2 Diabetes Inadequately Controlled With Metformin
Sponsor:
HighTide Biopharma Pty Ltd
Organization:
HighTide Biopharma Pty Ltd
Organization Data
Organization:
HighTide Biopharma Pty Ltd
Class:
INDUSTRY
Study ID:
HTD1801PCT109
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
HighTide Biopharma Pty Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Shenzhen HighTide Biopharmaceutical Ltd | UNKNOWN |